Andra AP fonden Raises Holdings in UnitedHealth Group Incorporated $UNH

Andra AP fonden boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 111,175 shares of the healthcare conglomerate’s stock after buying an additional 10,160 shares during the period. Andra AP fonden’s holdings in UnitedHealth Group were worth $46,208,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. State Street Corp grew its stake in shares of UnitedHealth Group by 0.7% in the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock worth $18,966,555,000 after buying an additional 301,081 shares in the last quarter. Premier Financial Group purchased a new position in UnitedHealth Group in the second quarter worth about $46,000. Security National Bank of SO Dak purchased a new stake in UnitedHealth Group during the second quarter valued at approximately $29,000. Security National Bank of Sioux City Iowa IA purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $62,000. Finally, Wellington Altus USA Inc. raised its holdings in UnitedHealth Group by 97.1% during the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 33 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.19% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on UNH shares. Oppenheimer boosted their price objective on shares of UnitedHealth Group from $420.00 to $500.00 and gave the company an “outperform” rating in a research report on Friday, July 17th. Erste Group Bank lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, August 27th. DA Davidson set a $512.00 price target on UnitedHealth Group in a report on Tuesday, July 21st. BMO Capital Markets set a $512.00 price objective on UnitedHealth Group in a research report on Tuesday, July 21st. Finally, UBS Group upped their price target on shares of UnitedHealth Group from $460.00 to $490.00 and gave the stock a “buy” rating in a report on Friday, July 17th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $456.56.

UnitedHealth Group Stock Down 0.6%

Shares of UnitedHealth Group stock traded down $2.32 during trading on Tuesday, hitting $375.24. 1,589,809 shares of the stock traded hands, compared to its average volume of 7,518,114. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a 52-week low of $255.96 and a 52-week high of $461.62. The stock’s fifty day simple moving average is $402.72 and its 200 day simple moving average is $372.13. The firm has a market cap of $336.81 billion, a P/E ratio of 24.13, a price-to-earnings-growth ratio of 1.42 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating the consensus estimate of $4.94 by $1.44. The business had revenue of $112.03 billion during the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 19.85 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be given a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group’s dividend payout ratio is presently 59.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.

UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.